SPIEGELMAN DANIEL K 4
4 · MYRIAD GENETICS INC · Filed Jun 2, 2023
Insider Transaction Report
Form 4
SPIEGELMAN DANIEL K
Director
Transactions
- Award
Common Stock
2023-06-01+15,151→ 49,131 total - Sale
Common Stock
2023-06-02$23.01/sh−8,638$198,760→ 40,493 total
Footnotes (2)
- [F1]Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.
- [F2]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.